Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
Friedreich AtaxiaThis project is a global, multicenter, prospective, longitudinal, observational natural history study that can be used to understand the disease progression and support the development of safe and effective drugs and biological products for Friedreich ataxia.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
0 and up
Participation Criteria
Inclusion Criteria:
1. Both males and females of any age
2. Individuals with Friedreich ataxia (FA): Participants that meet genetically confirmed diagnosis of Friedreich ataxia
3. Written informed consent provided
1. Informed consent must be obtained for all participants
2. For underage participants, they and the parent/ legally authorized representative have to sign the informed consent form, child assent (if applicable)
3. Persons who are not legally competent require the informed consent of their legally authorized representative
Exclusion Criteria:
4. Unable or unwilling to provide informed consent
5. Acute or ongoing medical or other conditions that would interfere with the conduct and assessments of the study
6. For any reason in the opinion of the investigator, participant would be unlikely or unable to comply with study protocol requirements.
Study Location
CHUM - Hopital Notre-Dame
CHUM - Hopital Notre-DameMontréal, Quebec
Canada
Contact Study Team
McGill University Health Centre - Montreal Neurological Institute
McGill University Health Centre - Montreal Neurological InstituteMontreal, Quebec
Canada
Contact Study Team
The Hospital for Sick Children
The Hospital for Sick ChildrenToronto, Ontario
Canada
Contact Study Team
- Study Sponsored By
- Friedreich's Ataxia Research Alliance
- Participants Required
- More Information
- Study ID:
NCT06016946